What drives innovation? Lessons from COVID-19 R&D
This paper studies the global R&D effort to fight the deadliest diseases. We find:(1) the
elasticity of R&D effort with respect to market size is about 1/2 in the cross-section of …
elasticity of R&D effort with respect to market size is about 1/2 in the cross-section of …
The economics of crisis innovation policy: A historical perspective
Since the beginning of the COVID-19 pandemic, policymakers, researchers, and journalists
have made comparisons to World War II. In 1940, a group of top US science administrators …
have made comparisons to World War II. In 1940, a group of top US science administrators …
The COVID-19 Innovation System: Article describes innovations that emerged during the COVID-19 pandemic.
BN Sampat, KC Shadlen - Health Affairs, 2021 - healthaffairs.org
The coronavirus disease 2019 (COVID-19) pandemic response brought forth major changes
in innovation policy. This article takes stock of the key features of the COVID-19 innovation …
in innovation policy. This article takes stock of the key features of the COVID-19 innovation …
Funding of pharmaceutical innovation during and after the COVID-19 pandemic
JC Robinson - JAMA, 2021 - jamanetwork.com
The coronavirus disease 2019 (COVID-19) pandemic has highlighted the available
mechanisms for funding research, development, manufacturing, and distribution in the life …
mechanisms for funding research, development, manufacturing, and distribution in the life …
Reboot biomedical R&D in the global public interest
S Swaminathan, B Pécoul, H Abdullah, C Christou… - Nature, 2022 - nature.com
Reboot biomedical R&D in the global public interest Skip to main content Thank you for visiting
nature.com. You are using a browser version with limited support for CSS. To obtain the best …
nature.com. You are using a browser version with limited support for CSS. To obtain the best …
Demythologizing the high costs of pharmaceutical research
DW Light, R Warburton - BioSocieties, 2011 - Springer
It is widely claimed that research to discover and develop new pharmaceuticals entails high
costs and high risks. High research and development (R&D) costs influence many decisions …
costs and high risks. High research and development (R&D) costs influence many decisions …
COVID-19: Insights from innovation economists
The present document provides the take of innovation economists on the COVID-19
pandemic. It targets the general public and focuses on questions related to the Science …
pandemic. It targets the general public and focuses on questions related to the Science …
Ecology and economics for pandemic prevention
For a century, two new viruses per year have spilled from their natural hosts into humans (1).
The MERS, SARS, and 2009 H1N1 epidemics, and the HIV and coronavirus disease 2019 …
The MERS, SARS, and 2009 H1N1 epidemics, and the HIV and coronavirus disease 2019 …
Leveraging open science to accelerate research
Leveraging Open Science to Accelerate Research Policymakers could incorporate open-
science principles into research policies and programs to optimize the return on federal …
science principles into research policies and programs to optimize the return on federal …
Pandemics show us what government is for
S Erikson - Nature Human Behaviour, 2020 - nature.com
Growth-at-any-cost economics has health costs, a reality the COVID-19 pandemic brings
into sharp relief. Governments must manage the tension between economics and health, but …
into sharp relief. Governments must manage the tension between economics and health, but …